Literature DB >> 31234713

uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Hung-Hsi Chen1, Woan-Yuh Tarn1.   

Abstract

Protein synthesis is tightly regulated, and its dysregulation can contribute to the pathology of various diseases, including cancer. Increased or selective translation of mRNAs can promote cancer cell proliferation, metastasis and tumor expansion. Translational control is one of the most important means for cells to quickly adapt to environmental stresses. Adaptive translation involves various alternative mechanisms of translation initiation. Upstream open reading frames (uORFs) serve as a major regulator of stress-responsive translational control. Since recent advances in omics technologies including ribo-seq have expanded our knowledge of translation, we discuss emerging mechanisms for uORF-mediated translation regulation and its impact on cancer cell biology. A better understanding of dysregulated translational control of uORFs in cancer would facilitate the development of new strategies for cancer therapy.

Entities:  

Keywords:  Translational control; cancer; cell stress; translation initiation; upstream open reading frame

Mesh:

Substances:

Year:  2019        PMID: 31234713      PMCID: PMC6779392          DOI: 10.1080/15476286.2019.1632634

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  139 in total

1.  Defect in the GTPase activating protein (GAP) function of eIF5 causes repression of GCN4 translation.

Authors:  Charles Antony A; Pankaj V Alone
Journal:  Biochem Biophys Res Commun       Date:  2017-04-04       Impact factor: 3.575

Review 2.  Principles of translational control: an overview.

Authors:  John W B Hershey; Nahum Sonenberg; Michael B Mathews
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

3.  Translation of upstream open reading frames in a model of neuronal differentiation.

Authors:  Caitlin M Rodriguez; Sang Y Chun; Ryan E Mills; Peter K Todd
Journal:  BMC Genomics       Date:  2019-05-20       Impact factor: 3.969

4.  Subtractional Heterogeneity: A Crucial Step toward Defining Specialized Ribosomes.

Authors:  Joseph W Briggs; Jonathan D Dinman
Journal:  Mol Cell       Date:  2017-07-06       Impact factor: 17.970

5.  Specific functional interactions of nucleotides at key -3 and +4 positions flanking the initiation codon with components of the mammalian 48S translation initiation complex.

Authors:  Andrey V Pisarev; Victoria G Kolupaeva; Vera P Pisareva; William C Merrick; Christopher U T Hellen; Tatyana V Pestova
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

Review 6.  A Cap for Every Occasion: Alternative eIF4F Complexes.

Authors:  J J David Ho; Stephen Lee
Journal:  Trends Biochem Sci       Date:  2016-06-06       Impact factor: 13.807

7.  A unifying model for mTORC1-mediated regulation of mRNA translation.

Authors:  Carson C Thoreen; Lynne Chantranupong; Heather R Keys; Tim Wang; Nathanael S Gray; David M Sabatini
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

8.  The role of eukaryotic translation initiation factor 6 in tumors.

Authors:  Wei Zhu; Gui Xian Li; Hong Lang Chen; Xing Yan Liu
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

9.  Translatome and transcriptome analysis of TMA20 (MCT-1) and TMA64 (eIF2D) knockout yeast strains.

Authors:  Desislava S Makeeva; Andrey S Lando; Aleksandra Anisimova; Artyom A Egorov; Maria D Logacheva; Alexey A Penin; Dmitry E Andreev; Pavel G Sinitcyn; Ilya M Terenin; Ivan N Shatsky; Ivan V Kulakovskiy; Sergey E Dmitriev
Journal:  Data Brief       Date:  2019-02-02

10.  eIF2β is critical for eIF5-mediated GDP-dissociation inhibitor activity and translational control.

Authors:  Martin D Jennings; Christopher J Kershaw; Christopher White; Danielle Hoyle; Jonathan P Richardson; Joseph L Costello; Ian J Donaldson; Yu Zhou; Graham D Pavitt
Journal:  Nucleic Acids Res       Date:  2016-07-25       Impact factor: 16.971

View more
  6 in total

1.  Ribosome profiling reveals translatome remodeling in cancer cells in response to zinc oxide nanoparticles.

Authors:  Saisai Wei; Wenhao Guo; Yu Qian; Jie Xiang; Kangli Liu; Xiang-Jing Gao; Xiangwei Gao; Yicheng Chen
Journal:  Aging (Albany NY)       Date:  2021-10-07       Impact factor: 5.682

2.  Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.

Authors:  Annika Nelde; Lea Flötotto; Klaus Wethmar; Lara Jürgens; Laura Szymik; Elvira Hubert; Jens Bauer; Christoph Schliemann; Torsten Kessler; Georg Lenz; Hans-Georg Rammensee; Juliane S Walz
Journal:  Cell Mol Life Sci       Date:  2022-03-03       Impact factor: 9.207

3.  Plants utilise ancient conserved peptide upstream open reading frames in stress-responsive translational regulation.

Authors:  Barry Causier; Tayah Hopes; Mary McKay; Zachary Paling; Brendan Davies
Journal:  Plant Cell Environ       Date:  2022-02-15       Impact factor: 7.947

4.  Translation of SARS-CoV-2 gRNA Is Extremely Efficient and Competitive despite a High Degree of Secondary Structures and the Presence of an uORF.

Authors:  Lionel Condé; Omran Allatif; Théophile Ohlmann; Sylvain de Breyne
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

5.  DAP5 drives translation of specific mRNA targets with upstream ORFs in human embryonic stem cells.

Authors:  Maya David; Tsviya Olender; Orel Mizrahi; Shira Weingarten-Gabbay; Gilgi Friedlander; Sara Meril; Nadav Goldberg; Alon Savidor; Yishai Levin; Vered Salomon; Noam Stern-Ginossar; Shani Bialik; Adi Kimchi
Journal:  RNA       Date:  2022-08-12       Impact factor: 5.636

Review 6.  Translational Regulations in Response to Endoplasmic Reticulum Stress in Cancers.

Authors:  Manon Jaud; Céline Philippe; Doriana Di Bella; Weiwei Tang; Stéphane Pyronnet; Henrik Laurell; Laurent Mazzolini; Kevin Rouault-Pierre; Christian Touriol
Journal:  Cells       Date:  2020-02-26       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.